| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Ocular Therapeutix, Inc.'s insiders have reduced their positions by a net 63,819 shares worth roughly $568K. In the past 30 days, 0 insiders bought and 3 sold. The bias lately has been to the sell side.
All 3 insiders who sold still hold shares after their sales. Classified under Biotechnology (Health Care sector), OCUL's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 3.27M | - | - | |
| COO | 366.5K | $3.75M | - | |
| Other | 326.9K | $3.52M | - | |
| Other | 307.5K | $2.17M | -10,869 | |
| Other | 300.1K | $2.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell10b5-1 | 1,858 | $8.20 | $15,235.60 | -0.6% | +30.0% | - | |
| May 26, 2026 | Kaiser Peter | Chief Development Officer | Sell10b5-1 | 2,967 | $8.20 | $24,329.40 | -1.1% | +30.0% | - | |
| May 26, 2026 | Heier Jeffrey S.61 | Chief Scientific Officer | Sell10b5-1 | 3,018 | $8.20 | $24,747.60 | -0.9% | +30.0% | - | |
| Feb 23, 2026 | Heier Jeffrey S.61 | Chief Scientific Officer | Sell10b5-1 | 3,057 | $8.28 | $25,311.96 | -0.9% | -1.5% | - | |
| Feb 23, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell10b5-1 | 1,759 | $8.28 | $14,564.52 | -0.5% | -1.5% | - | |
| Feb 23, 2026 | Dugel Pravin | See Remarks | Sell10b5-1 | 20,056 | $8.28 | $166,063.68 | -0.7% | -1.5% | - | |
| Feb 23, 2026 | Kaiser Peter | Chief Development Officer | Sell10b5-1 | 2,810 | $8.28 | $23,266.80 | -1.0% | -1.5% | - | |
| Feb 20, 2026 | Waheed Nadia | Chief Medical Officer | Sell10b5-1 | 3,510 | $7.74 | $27,167.40 | -1.1% | +5.7% | - | |
| Feb 20, 2026 | Lindstrom Richard L Md65 | Director | Buy | 60,229 | $7.66 | $461,354.14 | +32.3% | +5.7% | - | |
| Feb 12, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell10b5-1 | 10,348 | $9.04 | $93,545.92 | -3.0% | +2.0% | - |